AB0904 BELIMUMAB FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS: A PHASE 2/3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
C. P. Denton, R. Spiera, D. Jörg, D. Khanna, M. Kreuter, M. Kuwana, E. Volkmann, J. Cotic, O. Raji, A. Hammer, C. Zeccin, A. Van Maurik, J. M. Olaiz, W. Fahy, R. Tomlinson, D. Dastros-Pitei, S. Nihtyanova, E. Irving, T. Maher
Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1668; DOI: 10.1136/annrheumdis-2023-eular.1990